Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of oral GSK2190915 as add-on therapy in moderate to severe asthma with elevated sputum neutrophils
2008-007244-33Phase 2Terminated
- Sponsor
- GSK
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma and allergic asthma comparing GSK2190915 add-on with Placebo add-on (2 arms). Primary endpoint: Sputum neutrophil count. Started May 2009; status: terminated.
02
Drugs
fiboflapon
03
Conditions
asthmaallergic asthma
Beyond the preview
Go deeper on 2008-007244-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007244-33.